In humans, there is controversy as to whether MEF2C dysregulated and ETP-ALL feature a single disease entity or should be regarded as distinct groups (there is often partial discordance of immunophenotypic characteristics75,76). This evidence concerns the gene MEF2C and acute lymphoblastic leukemia.